Indian brothers lose appeal over pharma award
Daiichi Sankyo’s acquired a controlling stake in Ranbaxy Laboratories from the Singhs and other shareholders (Credit: Shutterstock/Julia Sudnitskaya)
The Singapore Court of Appeal has upheld a US$530 million ICC award that found Indian brothers Malvinder and Shivinder Mohan Singh liable for fraud over the sale of a pharmaceutical business.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Upgrade now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10